At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

Insulet announces the commercial launch of Omnipod 5 AID system in Australia, with Dexcom G6 and G7 CGM sensor compatibility.

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing ... first-ever accuracy and performance data for Dexcom G7 15 Day,1 will be presented, showcasing an overall mean absolute ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

He described how the system, which consists of two algorithms and a sensor ... in Continuous Glucose Monitoring (CGM) systems. Its wearable devices, like the Dexcom G6 and G7, provide real ...

you continuously wear a sensor that sends regular glucose readings to a smartphone app or insulin pump. Medicare Part B should cover several types of CGMs, including the Dexcom G7 or its earlier ...